• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于自闭症谱系障碍概念验证(POC)研究的平台试验方法:自闭症谱系概念验证计划(ASPI)。

A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI).

作者信息

Wathen J Kyle, Jagannatha Shyla, Ness Seth, Bangerter Abigail, Pandina Gahan

机构信息

Janssen Research & Development, NJ, USA.

出版信息

Contemp Clin Trials Commun. 2023 Jan 16;32:101061. doi: 10.1016/j.conctc.2023.101061. eCollection 2023 Apr.

DOI:10.1016/j.conctc.2023.101061
PMID:36949847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10025278/
Abstract

BACKGROUND

Over the past decade, autism spectrum disorder (ASD) research has blossomed, and multiple clinical trials have tested potential interventions, with varying results and no clear demonstration of efficacy. Lack of clarity concerning appropriate biological mechanisms to target and lack of sensitive, objective tools to identify subgroups and measure symptom changes have hampered the efforts to develop treatments. A platform trial for proof-of-concept studies in ASD could help address these issues. A major goal of a platform trial is to find the best treatment in the most expeditious manner, by simultaneously investigating multiple treatments, using specialized statistical tools for allocation and analysis. We describe the setup of a platform trial and perform simulations to evaluate the operating characteristics under several scenarios. We use the Autism Behavior Inventory (ABI), a psychometrically validated web-based rating scale to measure the change in ASD core and associated symptoms.

METHODS

Detailed description of the setup, conduct, and decision-making rules of a platform trial are explained. Simulations of a virtual platform trial for several scenarios are performed to compare operating characteristics. The success and futility criteria for treatments are based on a Bayesian posterior probability model.

RESULTS

Overall, simulation results show the potential gain in terms of statistical properties especially for improved decision-making ability, while careful planning is needed due to the complexities of a platform trial.

CONCLUSIONS

Autism research, shaped particularly by its heterogeneity, may benefit from the platform trial approach for POC clinical studies.

摘要

背景

在过去十年中,自闭症谱系障碍(ASD)研究蓬勃发展,多项临床试验对潜在干预措施进行了测试,结果各异,且未明确证明其疗效。缺乏关于合适的生物学靶点机制的清晰认识,以及缺乏用于识别亚组和测量症状变化的敏感、客观工具,阻碍了治疗开发的努力。一项针对ASD概念验证研究的平台试验有助于解决这些问题。平台试验的一个主要目标是通过同时研究多种治疗方法,使用专门的统计工具进行分配和分析,以最迅速的方式找到最佳治疗方法。我们描述了一个平台试验的设置,并进行模拟以评估几种情况下的操作特征。我们使用自闭症行为量表(ABI),这是一种经过心理测量验证的基于网络的评分量表,来测量ASD核心症状和相关症状的变化。

方法

解释了平台试验的设置、实施和决策规则的详细描述。对几种情况进行了虚拟平台试验的模拟,以比较操作特征。治疗的成功和无效标准基于贝叶斯后验概率模型。

结果

总体而言,模拟结果显示了在统计特性方面的潜在收益,特别是在提高决策能力方面,同时由于平台试验的复杂性,需要仔细规划。

结论

自闭症研究,特别是受其异质性影响,可能会从用于概念验证临床研究的平台试验方法中受益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/f317523b8352/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/2d355f202276/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/a9fa515b7816/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/4c475e6f7490/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/1032e8bc369f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/f317523b8352/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/2d355f202276/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/a9fa515b7816/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/4c475e6f7490/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/1032e8bc369f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3d7/10025278/f317523b8352/gr5.jpg

相似文献

1
A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI).一种用于自闭症谱系障碍概念验证(POC)研究的平台试验方法:自闭症谱系概念验证计划(ASPI)。
Contemp Clin Trials Commun. 2023 Jan 16;32:101061. doi: 10.1016/j.conctc.2023.101061. eCollection 2023 Apr.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder.自闭症行为量表:一种评估自闭症谱系障碍核心症状及相关症状的新型工具。
J Child Adolesc Psychopharmacol. 2017 Nov;27(9):814-822. doi: 10.1089/cap.2017.0018. Epub 2017 May 12.
4
Bayesian Design of Proof-of-Concept Trials.概念验证试验的贝叶斯设计
Ther Innov Regul Sci. 2015 Jan;49(1):155-162. doi: 10.1177/2168479014533970.
5
Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder.自闭症行为量表的临床验证:自闭症谱系障碍核心症状和相关症状的家长评定。
J Autism Dev Disord. 2020 Jun;50(6):2090-2101. doi: 10.1007/s10803-019-03965-7.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Qualitative evaluation of the Autism Behavior Inventory: use of cognitive interviewing to establish validity of a caregiver report scale for autism spectrum disorder.自闭症行为量表的定性评估:使用认知访谈法建立自闭症谱系障碍儿童照料者报告量表的有效性。
Health Qual Life Outcomes. 2021 Jan 20;19(1):26. doi: 10.1186/s12955-020-01665-w.
8
Diagnostic tests for autism spectrum disorder (ASD) in preschool children.学龄前儿童自闭症谱系障碍(ASD)的诊断测试。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD009044. doi: 10.1002/14651858.CD009044.pub2.
9
Neural mechanisms of behavioral change in young adults with high-functioning autism receiving virtual reality social cognition training: A pilot study.高功能自闭症青少年接受虚拟现实社交认知训练后行为改变的神经机制:一项初步研究。
Autism Res. 2018 May;11(5):713-725. doi: 10.1002/aur.1941. Epub 2018 Mar 8.
10
Designing and conducting proof-of-concept chronic pain analgesic clinical trials.设计并开展慢性疼痛镇痛概念验证临床试验。
Pain Rep. 2019 Feb 26;4(3):e697. doi: 10.1097/PR9.0000000000000697. eCollection 2019 May-Jun.

本文引用的文献

1
Systematic review of available software for multi-arm multi-stage and platform clinical trial design.系统评价多臂多阶段和平台临床试验设计的可用软件。
Trials. 2021 Mar 4;22(1):183. doi: 10.1186/s13063-021-05130-x.
2
Qualitative evaluation of the Autism Behavior Inventory: use of cognitive interviewing to establish validity of a caregiver report scale for autism spectrum disorder.自闭症行为量表的定性评估:使用认知访谈法建立自闭症谱系障碍儿童照料者报告量表的有效性。
Health Qual Life Outcomes. 2021 Jan 20;19(1):26. doi: 10.1186/s12955-020-01665-w.
3
The Bayesian Design of Adaptive Clinical Trials.
自适应临床试验的贝叶斯设计。
Int J Environ Res Public Health. 2021 Jan 10;18(2):530. doi: 10.3390/ijerph18020530.
4
I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer.I-SPY 2:一项旨在改善高危乳腺癌治疗效果的新辅助适应性临床试验。
Curr Breast Cancer Rep. 2019 Dec;11(4):303-310. doi: 10.1007/s12609-019-00334-2. Epub 2019 Nov 20.
5
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma.胶质母细胞瘤创新疗法个体化筛查试验(INSIGhT):一项贝叶斯适应性平台试验,旨在为胶质母细胞瘤患者开发精准药物。
JCO Precis Oncol. 2019 Mar 27;3. doi: 10.1200/PO.18.00071. eCollection 2019.
6
ASPI: a public-private partnership to develop treatments for autism.ASPI:公私合营致力于开发自闭症治疗方法。
Nat Rev Drug Discov. 2020 Apr;19(4):219-220. doi: 10.1038/d41573-020-00012-4.
7
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.帕博利珠单抗联合新辅助化疗对早期乳腺癌患者病理完全缓解的影响:正在进行的 2 期适应性随机 I-SPY2 试验分析。
JAMA Oncol. 2020 May 1;6(5):676-684. doi: 10.1001/jamaoncol.2019.6650.
8
Emerging biomarkers in autism spectrum disorder: a systematic review.自闭症谱系障碍中的新兴生物标志物:一项系统综述。
Ann Transl Med. 2019 Dec;7(23):792. doi: 10.21037/atm.2019.11.53.
9
The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0.欧洲预防阿尔茨海默病(EPAD)纵向队列研究:基线数据版本 500.0 发布。
J Prev Alzheimers Dis. 2020;7(1):8-13. doi: 10.14283/jpad.2019.46.
10
Adaptive platform trials: definition, design, conduct and reporting considerations.适应性平台试验:定义、设计、实施和报告考虑因素。
Nat Rev Drug Discov. 2019 Oct;18(10):797-807. doi: 10.1038/s41573-019-0034-3. Epub 2019 Aug 28.